Skip to main content

BioCommunique Article

Bringing you the latest financial and strategic news from top leaders in life science over the past two weeks.

Molecular Biologists at BioFluidica Leading Liquid Biopsy Revolution, More on the Scripps-Nvidia Partnership, Lilly Joins Forces with NextCure

  • 2018-11-08T22:28:00.000+0000
  • California
  • Author: Lauren Panetta

11/8/18 – Biological Dynamics
Biological Dynamics Awarded Grant to Develop the Next Generation of Smartphone-Enabled Tuberculosis Tests

11/8/18 – Crown Bioscience
Crown Bioscience Expands Cardiovascular & Metabolic Disease Research Capability

11/8/18 – OncoSec
OncoSec Appoints Robert Ward to its Board of Directors

11/8/18 – Pivot Bio
Pivot Bio, Bayer Announce Research Collaboration To Enhance Soybean Inoculant

11/7/18 – 10 News
San Diego Molecular Biologists at BioFluidica Leading Liquid Biopsy Revolution

11/7/18 – BioMed Realty
BioMed Realty Announces First Major Tenant At Gateway Of Pacific, The Latest Expansion Of Life Science, Technology And Healthcare Relationships In Its Bay Area Portfolio

11/7/18 – Alkahest
Alkahest Appoints Elizabeth Jeffords as Chief Commercial and Strategy Officer

11/7/18 – GenomeWeb
Scripps-Nvidia Partnership Melding Genomics, Sensor Data

11/7/18 – UC San Diego
Scientists Extend Mechanism for Cracking Biochemical Code

11/7/18 – Fluidigm
Fluidigm Recognized as a Company to Watch in 2019

11/6/18 – FierceBiotech
Lilly Joins Forces with NextCure to Fuel Immuno-oncology Expansion

11/6/18 – Otonomy
Otonomy Presents Data Highlighting Potential of OTO-413, an Otic Sustained-Exposure Formulation of BDNF, to Treat Hearing Loss

11/6/18 – Sorrento Therapeutics
Sorrento Therapeutics Anti-CEA CAR-T Demonstrates Significant Therapeutic Activity With Increased Overall Survival in Pancreatic Cancer Patients With Liver Metastases

11/5/18 – Xconomy
Eli Lilly Commits $40M to NextCure in Hunt for New Cancer Drugs

11/5/18 – GEN
Illumina Adds Long-Read Capabilities with $1.2B PacBio Acquisition

11/5/18 – Epic Sciences
Epic Sciences Joins Forces with Canadian Consortium of Investigators to Predict Late Recurrence of Metastatic Breast Cancer

11/5/18 – Poseida Therapeutics
Poseida Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for P-BCMA-101

11/5/18 – Arcturus Therapeutics
Arcturus Therapeutics Hosts Ribbon Cutting Ceremony for its Research and Development Facility

11/1/18 – Agena Bioscience
Agena Launches Bone Marrow Engraftment Assay For Chimerism Analysis

10/31/18 – Heron Therapeutics
Heron Announces FDA Submission of HTX-011 NDA for Postoperative Pain Management

10/31/18 – ACADIA Pharmaceuticals
ACADIA Pharmaceuticals Announces Positive Top-line Results from Phase 2 CLARITY Trial of Pimavanserin for Adjunctive Treatment in Patients with Major Depressive Disorder (MDD)

10/30/18 – San Francisco Business Times
10x Genomics Takes Gene Imaging and Analysis Tools to the Big Leagues

10/30/18 – Illumina
Illumina Launches TruSight Oncology 500 to Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling

10/29/18 – FierceBiotech
Big Pharma Rivals Pfizer and Novartis Team up on NASH